Global Contraceptive Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Contraceptive Market Research Report 2024
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
According to MRAResearch’s new survey, global Contraceptive market is projected to reach US$ 2478.8 million in 2033, increasing from US$ 1911.9 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Contraceptive market research.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Contraceptive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bayer
Merck
Church & Dwight
Warner Chilcott Company
Pfizer
Ansell Limited
Mylan
Teva
Segment by Type
Contraceptive Drugs
Contraceptive Devices
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Contraceptive report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Contraceptive market is projected to reach US$ 2478.8 million in 2033, increasing from US$ 1911.9 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Contraceptive market research.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Contraceptive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bayer
Merck
Church & Dwight
Warner Chilcott Company
Pfizer
Ansell Limited
Mylan
Teva
Segment by Type
Contraceptive Drugs
Contraceptive Devices
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Contraceptive report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source